Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
They .. need sellers .. today to make..the..steal
Why not keep it real???? These fools simply can not do what they say when they say. Soooooonnnnnnnn ehh? Days to weeks....... Ipf in box stores in March...... Next support is just north of a penny and the real support is where the pumpers that are getting scared bought in at .006
Coicendently that is two pump and dumps away based off taking out every low by 65% pattern that's been goin on. Rember MACRO lol
Well said Dyno89! Keeping the faith here!
Not at all. Just Saying that I believe he knows who is in control and why, not that he is necessarily responsible. I guess he could be responsible if we find out that PUMA has actually been buying back shares for the co. (I’m not saying this is happening)
So what you are saying is that a company can get a MM to control your stock for a reason?
There's our sign/indicator that they're not gonna let it move today... INTL moving from their ask from their normal perch at 0.63 to .042. They don't actually want to sell a single share, they're just doing their part to hold it/deter... Completely normal though, right? I mean people buy shares all the time at > .09/.10 and then throw them on the ask for less than half of that, don't they? LOL...
Oh well, I guess it really doesn't matter what INTL does anyway, seeing as PUMA is still playing their game? If today plays out as expected, we'll be looking at next Wednesday as the earliest anything significant could drop. I still don't think the muzzle comes off until 2023, but next Wednesday-Friday would still be in the realm of possibility. Unlikely, but possible.
Thanks, TK. Hopefully they have updated these tests against what's the market now.
Although I'm sure others will disagree, Yes. I 100% absolutely believe that he knows who is in control and why... 19-20 months of some of the most obvious, coordinated, & aggressive manipulation, yet it has gone completely unchecked/unaddressed by Charles/ENZC. There has to be a reason for this.
You are making this too easy!
Audit Issues........
Originally ENZC put out a pr stating they were looking to hire a PCAOB auditor and eventually up list to the OTCQB back in Jan 2021. They hired Malone & Bailey in Feb 2021. So far so good. In June, ENZC was informed that instead of being a business combination, that it should have been a merger between them and Bioclonetics. Well, obviously a huge deal and with probably enormous consequences as far as tax purposes and such, ENZC was then required to also audit Bioclonetics for 2019 & 2020.
ENZC then contends that it should have always been a business combination, and hires a outside account consultant with specialties in this matter, Steve Heumann. The 3 sides apparently work things out, ENZC is transparent with all the information requested of them that the auditors and Steve need, so then it seemed just a matter of time. Hence the reason Dr C made the comment he thought it could be days to weeks when we see the audit, and that was early 2022. Months go by and nothing is happening, all the while Charles contends in his quarterly reports that there is no problems or further questions.
Now it's mid summer, and we find out that ENZC has let go of M&B and brought on a new auditor from Greis & Associates, Blaze Greis. The million dollar question is why? Why the switch after almost a year and half with M&B, and so much time and effort put into them getting this audit done? This is where you have to speculate, but my guess would be they simply were taking too long and just couldn't get it done for whatever reason. Do you wait longer if you are ENZC and stick with M&B to see it through? Or do you simply cut ties and hire someone else who you feel can get the job done in a timely manner? They ended up choosing the later.
So, moral of the story is ENZC was in a lose-lose situation at the time they let go M&B, knowing either way it would take a lot more time to get the audit done either way it went. Optically it looked bad, and investor confidence was lost.
But under no scenario do I believe this was a scam or Dr C was leading investors when he said days/weeks. This audit getting done is obviously huge to ENZC, definitely not required and voluntary on their part, but important enough that only a month after the business combination they were already thinking to get audited fins. When will the ever seemingly elusive audited fins come out? No definitive answer, but as long as Blaze has everything he needs from the co, and there are no remaining issues if any to be resolved, we should see them here fairly soon.
I also believe confidence can and will be restored here with ENZC, once they start selling IPF and audited fins are reported.
Forward looking statements are just that, and I think they always intend to paint the best case scenario if everything went perfectly. But I also believe the intent and determination is there to achieve all the milestones they have set out, just not in the exact timeframe that they have given. I think they have been more mindful of this overall, except for the latest one where they said IPF would be available in November.
Dyno. You make a great and indisputable NO DILUTION point. Scams always dilute to take your money. R/S indefinitely
Dyno appreciate reading. .good post/ with this..having significant and basic infm .. not only that but is more of an explanation on what the basis of certain claims are and what actually does get a lot of attention by intelligent investors and buyers of a company stock.. vs claims that need a certain amount of pertinenance to important issues.
And here is a little snippet from the article written about Clone 3 back in 2013......
Then, in August 2010, came another
landmark for Clone 3. The U.S. government’s
Los Alamos HIV Clinical Database published
a review of Clone 3 antibody’s capacity to bind
directly with the 2,229 (then) known strains
of HIV around the world. By searching the
surface (amino acid) composition of these
2,229 HIV isolates, Los Alamos found that
ninety-eight percent of them have an exact
match—or conservative amino-acid substitu-
tion—for the minimal essential “core” epitope
KLIC to which the CLONE 3 antibody binds.
In other words, Clone 3 epitope KLIC has
the potential to elicit, in active vaccination, a
protective antibody (“CLONE 3”) that broadly
neutralizes ninety-eight percent of all known
HIV strains. This is more than any other
vaccine candidate whose study results have
been published.
The reason why Dr Fauci and the NIH were going after this antibody because they knew the power it had, and more than likely they were just going to shelve it to continue with their policy of selling drugs and not a cure. Under oath we know that Dr Fauci said it had "utility" & "commercial value" at that time. But lucky Dr Cotropia beat them to the punch and had already patented Clone 3 in 1989, hence why the judge ruled in their favor since it had already been patented 10 yrs prior.
Hey Valuator, no problem and here you go. From the Bioclonetics former funding page which is no longer active.......
As we have earlier reported, our parent monoclonal antibody has been previously tested in 5 international labs and shown to effectively neutralize multiple HIV isolates (strains of the virus) (http://www.bioclonetics.com/validation.html). From the parent antibody, we have prepared the required recombinant antibodies, required by the FDA for use in patient therapy, and initial tests have been conducted at the Institute of Tropical Medicine, University of Antwerp, Belgium.
From these tests results, the effectiveness of our recombinant antibody as compared to all other anti-HIV monoclonal antibodies thus far produced by pharma and the NIH, our recombinant tested at 2.6 times more effective than the best no. 1 antibody – VRC01 – and 6 times more effective than the no. 2 next best anti-HIV monoclonal antibody – VRC01 – (both produced by Vaccine Research Center, in conjunction with the NIH). We are conducting additional tests on our recombinant antibodies at The Scripps Institute in California and at Responsive BioServices in Georgia.
Rockie .do.,you..think that is..basicly..just a .. question infering it' could have an answer that is..at the surface taken as the obvious. . if and when , it's asked.. at any point of price lows..
That leads to another one so it would ..go without saying.
Which leads to aniother question much more below the surface does a CEO release his infm that could or in some cases should be on the.. basis of watching his own corp. stock price at certain levels.
Nope. There is a difference between a amateurishly run company and a scam. Sorry, the “scam” claims have never held any weight here. No intelligent investor has or will ever believe them either. And there are many indisputable reasons why.
There are numerous major partnerships ongoing with well known, legitimate, established companies. Those WOULD NEVER occur were this a “scam”.
There are multiple partnerships and collabs with well known Universities world wide. Those would not happen were this a “scam”
There are multiple advisors and board members, all well known with solid reps. Again, these would not happen were this a “scam”.
And maybe the biggest proof of all this isn’t a “scam”. There is no dilution.
End of story. Any company running a stock scam is actively diluting, bc otherwise there is literally no purpose to be scamming investors.
These guys have run this small bio company two years in without diluting. That fact alone is all anyone needs to know when questioning the “scam” claims.
They have a long way to go with improving investor confidence at this point and improving the way the company is run and finally getting things in order and milestones met. But this is no scam. 100% fact. Nothing else to say.
TK, I agree with your thoughts. Can you share where you got those stats on Clone 3? Thanks!
MAGA do you think Charles knows exactly how and why the stock is trading the way it has for last several months.
They..want.shares..watchin,.smart..money..swooping..down.to.. steal~ Along with them Now+thinking Billionaire Buffet smart money guy as he goes after shares to buy the company. . He says he..is buying the company with his shares and getting rich .. knowing what Is going on behind the scenes
He also says in online intvw how would I know what price is tomorrow I buy the corp in shares and then I had started getting rich
And went on to say
that was my error before I was in my 50's and why it happened in that period
Because
It was an.. Error ....not to think this way in earlier times
Which also means at these levels there is some thinking this
..
.. owning a part of the Co. in shares and waiting is not the worst at prices as this
Thank God .. thank heaven we are not...paying ..15 - .,30 so we can all get rich with any assets in
2b - I don't have any doubt that they are trying to squeeze/steal shares from scared retail.
It all started with the organized takedown during the emerging growth conference. That was the starting point. There were a bunch of FTD's and they desperately needed to cover. After that, the manipulation went into overdrive in early January 2022 with VIRT+OTCX, who successfully drove this under from .16 to under .10, then disappeared. A few days later we broke .10 again, and both VIRT+OTCX immediately popped back in completely synced up, drove us comfortably under .10, then disappeared for good. It was 100% organized/coordinated, and has not stopped except to reset the RSI every few months.
Let us hope for the best. The wait is only getting shorter.
No worries.
MP...If..were...pos'..to.say ..good,,news..new..opp'..for..ppl..to..get..wealth_ riding this breakthrough cure to aids.. as millions of lives get saved around the world after being infected..with buyers getting a new chance and possibly the last chance!!
Which it may just be that.. as a possible last chance vs all the put down taking up the perspective of the messages sounding as of it's a negative.. helping sidelines sit as the American eagle to swoop down and buy as low as imagination can take it and take shares from frightened holders.. As this being _ the [American way ]
Instead of talking as Warren Buffet who said he did not get his wealth Quoting avail online in so many words
He was saying he did not know the price the next day
He decided to buy stocks as a way to buy into companies knowing what they were doing ..
And that's when he stopped losing out and got wealthy after he reached the 50's and was buying stock from mid teens
And he pointed out how many years it took to realize the error of not doing it that in that way
But ., we read much less about it being said as muzzled said to infdr a put down.. ? And yet sidelinees holding there powder must love the put down
Thank God the guy knows when to release infm and he may be giving newbies a last chance
A last chance..
.. to again buy bottom prices it would be in the right perspective to the opportunity as it presents itself and why the shorts help traders who are smart money to follow the way down and come in with shorts where they buy in.
Instead it appears as the infm looking as a negative posting
Yet fortunes are made when prices are beaten down buy thus method of shorts and the smart money followed it
What happened 19 or 20 months ago that might be the reason for holding the price down for that amount of time.
Well it makes me feel better knowing I'm not the only one that has screwed up with stock trading.
I know hind sight is perfect but the first stock I bought was Walmart 1000 shares IF I had kept Walmart through the years and 8 2 for 1 splits I would have 256,000 shares today at 150.00 per share now......but it doesn't bother me.
Given everything we know as fact right now, we should be trading at .25-.35, and that is an ultra-conservative valuation. 0.35 puts us at a $990M MC, but they've done such a good job at destroying this over the past 20 months that we can't even break a nickel. That $990M market cap is about 1/10 of projected annual earnings for C3 for HIV alone. Without factoring in any PE/multiplier. Our current severely undervalued pps is an absolute joke.
I agree and that's one of 3 or 4 reasons I'm not selling until we get to AT LEAST a BUCK.
That sounds like me with Microsoft... Yeah, different because everybody knows it, but I had it at $47 as a rookie and sold at $49 and it went North of $300 before the crash...
I said "WOW... 2 Grand!" and sold... Oh well.
I will say this... There is a reason that this has been manipulated and beat down to the extent it has. A ton of time and effort have went into beating the crap out of this/holding it down, and attempting to get retail to sell; and they're not doing it for their health.
If everything turns out good I'll have even a better story...here's hoping.
I did too rockie.... I was stubborn. Had nothing to do with holding for more, and everything to do with not wanting to give IL the taxes (was living in IL then). If it would've happened 1-2 months later, I would've been in long term holdings and would've sold. Oh well.... Live and learn...
Honestly Dusty, your guess is as good as mine. Although they sure do dangle it a lot..
That's me in Feb.-March 0f 2022 turned down million and halt AFTER taxes in 6 1/2 months on a 48 thousand investment didn't think it was time to sell....ENZC was one of the stocks...WON'T DO THAT AGAIN...THAT' A HOG CURED FACT.....at that time there was talk of ENZC going too many dollars.
Although it was a small trial size, ITV-1 was already successful in a phase 3 clinical trial in Bulgaria.
As far as Clone 3, the parent monoclonal antibody was shown to be 2.6x more powerful than the govt NIH antibody, hence the reason Fauci tried to basically steal it, but lost that battle. The new recombinant form of Clone 3 is shown to be 30x more powerful than the parent antibody.
So this is why your investing here imo. A drug that was already successful, but because of a host of reasons and some shady characters in Bulgaria, was never brought to market.
And then you have Clone 3, which showed amazing efficacy in vitro compared to anything else, but somehow never was able to get the funds necessary to bring the drug to market.
Brining any drug to market is a longshot, and it a very long arduous process even if successful. ENZC definitely has a shot, but the road and process will be a long and bumpy one, filled with many ups/downs along the way. It's impossible to judge the success/failure of ENZC when they have just started the race.
That is exactly one of the reasons that I'm still here. I was in a stock back in 2017/2018 (diabetes ticker) and I bought roughly 10K shares for around 2.30 per share. It went up to around $5, and although my gut was telling me to hold, I sold and pocketed close to $30K. I was still pretty new to trading back then, so once I sold it, I moved on and didn't pay much attention to it for awhile. However, unbeknownst to me, it never stopped going up. and closed out 2018 at about $38, but still wasn't finished. In January 2022 it was trading at $150. It's since fell back to around $40-$50, but I promised myself I would never make that mistake again.
PCAOB AUDITORS
On January 11, 2021, the Company engaged Malone Bailey to perform the Audit for the years ended December 31, 2019 and 2020.
The Company completed the client approval process in early February. No unanswered accounting issues arose. It was determined in
June of 2021 that the Bioclonetics transaction, which closed in November of 2020, should be accounted for as a reverse merger rather
than a business combination and will be reported as such in the audited financials for ENZC. The requested change in accounting
method required the books and records of Bioclonetics to be audited for the years ended December 31, 2019 and 2020 in accordance
with GAAP standards by a PCAOB auditor. After the hiring of independent Accounting Consultants, it was determined that the
Companies did do a business combination not a reverse merger, and as of the time of this filing, the Company has provided all the
records and agreements, accounting memos and backup documentation requested by the consultant and the auditor. The Changes in
Accounting Method will result in amendments to the quarters ending March 31. 2021, June 30, 2021, and September 30, 2021
immediately upon completion of the audits. In July of 2022, the Company and Malone Bailey terminated their relationship. There
were no unresolved accounting or financial issues between the parties. Gries and Associates, LLC was retained on July 18, 2022, and
is in the process of completing the 2020-2021 audits.
9
All theories have merit. Trade your shares or hold ir sell. Waiting to buy is old idea. Some bought cheap with a reverse merger and ideas before partners.
Sure... Anything's possible, but at the end of the day none of it will matter if somebody else beats us to the finish line. Especially if that somebody is already a household name....
I share concerns that everybody has stated, that's just Human nature... Then I think about the careers of the people in charge and I don't worry anymore.
It doesn't look like anything will happen this year, but I'm not going anywhere until Little Baby Jesus says so no matter what, so I'm just chillin. I have been with horrific companies in the past and am still with IBIO that is winding down from the former CEO / Con Artist...
ENZC is all good.
Audit comes after Savov case complete IMO.
Audit comes after Savov case complete IMO.
MAGA maybe Charles knows the news that he is holding is so big nothing else will matter.
You can't even think....go back to your sand box.
I haven't heard a good answer for the audit being months to a year late. What is the issue? Thought is was the key to our (my fellow bagholders) future. Big boys can invest in. Companies legit. Big deals about to happen. At 4 cents. What a lottery ticket. $ENZC! $ENZC
The board of useless BS is entertaining!
No. Can't sue for them keeping hush hush, nor would we want to. However, I'd be lying if I said that I wasn't a bit worried as well. Not so much with their tech/science, but with somebody beating us to the finish line. Since Charles has been wearing a muzzle for so long, the world has no idea who ENZC is, which would play in any well known competitors favor, should they + ENZC end up going to market at the same time.
We'll need to continue waiting and hope that we live long enough to see a break from over promise-under deliver and/or see just 1 of the many missed/late milestones fulfilled. Like I've been saying, Charles could not be anymore predictable than what he's been, so I personally already consider December over, and just waiting to see how low they take it. Charles will likely drop another fluff "PR" where he dangles the audit again, as well as few other carrots, but as usual will not actually deliver anything tangible. I'm hoping that changes in 2023
Of course you should be worried. Any sane investor would be. This isn’t a “scam” by any means, but that doesn’t mean it’s a well run business either. These guys have repeatedly failed to meet any milestones. Two years in and we have nothing so far.
We were told 4 products to market in 2022 and there’s 2 weeks left in 2022 ffs. Are we even going to get 1? Or will these clowns go 0 for 4?
Two years since we were told the audit was coming.
Nearly a year since “days to weeks” for the audit completion.
The worst imo and the breaking point for me personally with trusting these guys ever again was the official PR in November stating IPF would be to market “this month”. That was last month and there’s still nothing. If something happened that was out of their control, well then they need to issue an official follow up to explain that to shareholders.
Who could blame some of us for being absolutely livid at this point?
MAGA to tell the truth I'm WORRIED about everything concerning ENZC.....but at this point can't sell at such low price.....if information is being kept hush hush can shareholders sue ?
Followers
|
1251
|
Posters
|
|
Posts (Today)
|
14
|
Posts (Total)
|
199649
|
Created
|
01/07/10
|
Type
|
Free
|
Moderators Homebrew Timing101 archilles SeniorApollo |
Independent Valuation Report Pre Clinical Studies
Investments
___________________________________________________________________________________
Press Release July 20-2021
Enzolytics Announces the Signing of a Letter of Intent with Creative Biolabs, Inc.
for Licensing and Commercialization of anti-HTLV-1 Monoclonal Antibodies
https://www.creative-biolabs.com/
https://finance.yahoo.com/news/enzolytics-announces-signing-letter-intent-113000339.htm
________________________________________
Press release July 21-2021
Enzolytics and Lonza Bioscience Combine Technologies to Fast-track Development and
Production of Anti-HIV and Anti-SARS-CoV-2 Monoclonal Antibodies produced by Enzolytics
https://www.lonza.com/
https://www.bloomberg.com/press-releases/2021-07-21/enzolytics-and-lonza-bioscience-combine-technologies-to-fast-track-development-and-production-of-anti-hiv-and-anti-sar
_________________________________________
July 22 INTERVIEW
with
James Hicks, Charles Cotropia and Gurav Chandra
http://www.youtube.com/watch?v=mdljO9VLgj0
______________________________________________________________
COLLEGE STATION, TX August 25, 2021
Important Excerpt from this news progress update.
>>>>>><<<<<<
"The monoclonal antibodies being produced by Enzolytics against the CoronaVirus target 19 conserved immutable sites on the virus, sites which the Company has now confirmed are conserved sites not only on the initial virus strains but also existing in the Delta and Lambda variants, as well as in the Alpha, Beta and Gamma variants."
Enzolytics Inc. and Samsung Biologics Announce
Development and Manufacturing Agreement for Anti-
HIV and Anti-SARS-CoV-2
Important Excerpt from this news progress update.
>>>>>><<<<<<
"Samsung Biologics (KRX: 207940. K.S.), a leading contract development and manufacturing organization and Enzolytics (ENZC), a drug development company committed to commercializing multiple proprietary therapeutics to treat debilitating infectious diseases, announced the signing of a strategic CDMO partnership agreement."_______
2000 North Central Expressway
Plano, TX 75074
972-292-9414
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |